Smith, Richard

Smith, Richard was paid $111K by Medicaid between Jan 2018 and May 2023, across 3 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 47% of everything it billed.

33Billing provider infoSMITH, RICHARD
PUTNAM, CT 06260

33aNPI1215993993assigned 04/22/2006

33bProvider typePediatrics Physician

28Total paid$111K

24GClaims1,975

24DCodes billed3

24AFirst – last monthJan 2018 – May 2023

Compared with peers

Next to other Pediatrics Physician providers in Connecticut

Rank by total paid#103 of 162

Median peer was paid$313K

This provider vs. median0.4×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	238	$11K
2019	40	$3K
2020	628	$36K
2021	647	$37K
2022	349	$20K
2023	73	$5K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	47%	1,085	814	$52K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	30%	487	387	$33K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	23%	403	305	$26K

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.